Scaling trials across sites can lock in supply risk early. Learn how biologic variability, long lead times, and multisite complexity threaten trials and how to spot warning signs fast.
- Building A Culture Of Compliance In Clinical Supply
- Global Clinical Supply Chain in Emerging Markets: Reliability, Compliance, Access
- Clinical Supply Is Not A Fix-It Function. It's A Planning Function.
- Sales & Operations Planning for Small Teams: Aligning Clinical Supply
- The Trends Shaping Clinical Trial Supply
- What 2025 FDA Warning Letters Tell Us About GMP Compliance
- Clinical Supply's Role In Driving Success In Decentralized Trials
- Phages As A Pharmaceutical: New EMA Guidance On Antimicrobial Drug Development
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Integrating Early-Phase Clinical Supply Manufacturing & Distribution
A tablet formulation was a solution when developing a new class of anti-infective medicine, allowing the integration of formulation development, clinical trial material (CTM) manufacturing, and supply and distribution to patients.
-
RTSM/IRT In Clinical Trials: The Complete Guide
RTSM/IRT systems are essential to modern clinical trials. This guide explores how to implement and optimize them to boost efficiency, streamline operations, uphold study integrity, and ensure compliance.
-
How Direct-To-Patient Models Can Provide Clinical Supply Chains With An End-To-End Solution
Analyze the benefits and challenges of implementing direct-to-patient services in the clinical supply chain to help meet patient requirements, improve supply chain efficiency, and accelerate speed to market.
-
Creating A Sustainable Pharmaceutical Supply Chain
Learn how CDMOs can drive transformation in the supply chain and create a more sustainable future for the pharmaceutical manufacturing industry.
-
Building A Flexible, Challenge Resistant, Patient-Centric Clinical Supply Chain
Flexible solutions, like demand-led supply and direct-to-patient distribution, are helping sponsors address the growing list of challenges presented by today’s increasingly complex studies.
-
Controlled Substances In Clinical Trials
Handling controlled substances presents layers of complexity. Partnering with an experienced CDMO is essential for managing scheduled materials during clinical studies.
-
Solutions For Sponsors Utilizing Drafted Guidance For PROs In Oncology
Explore the challenges pharmaceutical companies face in implementing PROs in cancer clinical trials as outlined in the FDA’s draft guidance, as well as strategies to overcome these obstacles.
-
How Clinical Trial Complexity Impacts End Users
This article examines clinical trial complexity through the lens of study investigators, site staff, CRAs, sponsor study and supply managers, and how the RTSM/ IRT provides the ability to be as creative as needed.
-
Transforming Clinical Supply Planning From Spreadsheets To Smart Forecasting
Streamline your clinical supply forecasting and reduce risk by moving beyond manual spreadsheets to an integrated, real-time supply management solution.
-
Key Considerations For Packaging Solutions For Cell And Gene Therapies
Thinking of packaging and delivery factors early and often will minimize risks to the safety and efficacy of your cell and gene therapy drug product from the bench to the patient.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.